Loading clinical trials...
Loading clinical trials...
The lifetime risk for development of atrial fibrillation, the commonest sustained arrhythmia in adults, is estimated to be 24%-27% for individuals of 40 years or older. Previous work showed that annua...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Chinese University of Hong Kong
NCT06378996 · Mitral Valve Prolapse, Ventricular Arrythmia
NCT07196397 · Vasovagal Syndrome VVS, Cardioinhibitory Carotid Sinus Syndrome CSS, and more
NCT06889662 · Myocarditis, Ventricular Arrythmia
NCT04521790 · Myocarditis, Ventricular Arrythmia, and more
NCT05964660 · Ventricular Arrythmia
Prince of Wales Hospital
Hong Kong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions